|
|
|
|
||
Neuroendocrine Tumor Research Foundation grant "Satya Das, MD, has been awarded a $300,000 grant for a two-year period by the Neuroendocrine Tumor Research Foundation. The grant supports his research combining the targeted therapy cabozantinib and the glutamiase inhibitor CB-839 in a clinical trial to assess the synergy of these antitumor treatments on small intestine and pancreatic neuroendocrine tumor patients." |
return to message board, top of board |